Data as of Mar 10
| -0.10 / -4.61%|
The 3 analysts offering 12-month price forecasts for Catalyst Pharmaceutical Partners Inc have a median target of 4.00, with a high estimate of 6.00 and a low estimate of 3.75. The median estimate represents a +93.24% increase from the last price of 2.07.
The current consensus among 3 polled investment analysts is to Buy stock in Catalyst Pharmaceutical Partners Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.